Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

NCT02581163 · clinicaltrials.gov ↗

COMPLETED

Status

314

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C, Genotype 1 or 4

Interventions

DRUG: Ombitasvir/paritaprevir/ritonavir
DRUG: Dasabuvir
DRUG: Ribavirin

Sponsor

AbbVie

Collaborators

[object Object]